Elisabeth Leiderman

Director/Board Member at AUTOLUS THERAPEUTICS PLC

Net worth: - $ as of 2026-06-29

49 year

Health Technology

Consumer Services

Profile

Elisabeth Leiderman is currently Non-Executive Director at Autolus Therapeutics Plc since 2023 and Chief Financial Officer at Dewpoint Therapeutics, Inc. starting in 2024.
Former roles include Independent Director at Genetix Biotherapeutics, Inc. from 2021 to 2025, Chief Financial & Business Officer at Atsena Therapeutics, Inc. from 2022 to 2023, Chief Financial & Accounting Officer at Decibel Therapeutics, Inc. from 2021 to 2022, Chief Business Officer at Complexa, Inc. from 2016 to 2020, Executive Director at Nomura Securities, Inc. from 2013 to 2016, and VP-Business & Corporate Development at Fortress Biotech, Inc. from 2007 to 2016.
Education includes undergraduate studies at the University of Pennsylvania, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from Sackler School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AUTOLUS THERAPEUTICS PLC -.--%	2026-06-28	0 ( -.--% )	- $	2026-06-29

Elisabeth Leiderman active positions

Companies	Position	Start
AUTOLUS THERAPEUTICS PLC	Director/Board Member	2023-12-19
Dewpoint Therapeutics, Inc. Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company	Director of Finance/CFO	2024-05-31

All active positions of Elisabeth Leiderman

Former positions of Elisabeth Leiderman

Companies	Position	End
GENETIX BIOTHERAPEUTICS, INC.	Director/Board Member	2025-06-01
Atsena Therapeutics, Inc. Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness	Director of Finance/CFO	2023-10-31
DECIBEL THERAPEUTICS, INC.	Director of Finance/CFO	2022-10-06
Complexa, Inc. Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases	Corporate Officer/Principal	2020-07-31
Nomura Securities, Inc.	Director/Board Member	2016-06-30

See the detail of Elisabeth Leiderman's experience

Training of Elisabeth Leiderman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elisabeth Leiderman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Fortress Biotech, Inc. Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
bluebird bio, Inc. bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells	Health Technology
Complexa, Inc. Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases	Health Technology
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sackler School of Medicine Sackler School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Decibel Therapeutics, Inc. Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders	Health Technology
Autolus Therapeutics Plc Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies	Health Technology
Dewpoint Therapeutics, Inc. Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company	Health Technology
Atsena Therapeutics, Inc. Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness	Health Technology
Nomura Securities, Inc.